Does SARILUMAB Cause C-reactive protein abnormal? 588 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 588 reports of C-reactive protein abnormal have been filed in association with SARILUMAB (KEVZARA). This represents 2.7% of all adverse event reports for SARILUMAB.
588
Reports of C-reactive protein abnormal with SARILUMAB
2.7%
of all SARILUMAB reports
456
Deaths
529
Hospitalizations
How Dangerous Is C-reactive protein abnormal From SARILUMAB?
Of the 588 reports, 456 (77.6%) resulted in death, 529 (90.0%) required hospitalization, and 500 (85.0%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARILUMAB. However, 588 reports have been filed with the FAERS database.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which SARILUMAB Alternatives Have Lower C-reactive protein abnormal Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE